COMPANY
Crescent Biopharma
FDA-cleared device company Clinical Phase 2
Hiring
| Title | Location (from posting) | Employer posted | First seen |
|---|---|---|---|
| Director, Program Management | Waltham, MA | Oct 20, 2026 | Oct 21, 2026 |
| Senior Manager / Associate Director, Clinical Sample Operations | Waltham, MA | Oct 15, 2026 | Oct 16, 2026 |
| Director, Talent Acquisition | Waltham, MA | Oct 2, 2026 | Oct 11, 2026 |
| Executive Director/Vice President, Corporate Development | Waltham, MA | Aug 21, 2026 | Oct 11, 2026 |
| Director, ADC Drug Substance | Waltham, MA | Aug 13, 2026 | Oct 11, 2026 |
Timeline
- Raise Follow-on offering: $125M (total, as published), announced Jul 14, 2026. Source: SEC filing. source ↗
- Trial start Phase 1/Phase 2: CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors source ↗
- Raise Private placement: $185M (total, as published), announced Dec 4, 2025. Source: SEC filing. source ↗
- Partnership Partnership / licensing announced Dec 4, 2025. Source: SEC filing. source ↗
Upcoming milestones
- 2029-02 (ESTIMATED) · Phase 1/Phase 2 · CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors · NCT07335497
Funding
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07335497 | CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors | Phase 1/Phase 2 | Recruiting | Feb 17, 2026 | 2029-02 (estimated) |
Open jobs 11
| Title | Location (from posting, not HQ) | Employer posted | First seen | Level |
|---|---|---|---|---|
| Director, Program Management | Waltham, MA | Oct 20, 2026 | Oct 21, 2026 | Not stated |
| Senior Manager / Associate Director, Clinical Sample Operations | Waltham, MA | Oct 15, 2026 | Oct 16, 2026 | Not stated |
| Director, Talent Acquisition | Waltham, MA | Oct 2, 2026 | Oct 11, 2026 | Senior |
| Executive Director/Vice President, Corporate Development | Waltham, MA | Aug 21, 2026 | Oct 11, 2026 | Executive |
| Director, ADC Drug Substance | Waltham, MA | Aug 13, 2026 | Oct 11, 2026 | Senior |
| Director/Senior Director, Drug Product | Waltham, MA | Aug 13, 2026 | Oct 11, 2026 | Senior |
| Executive Assistant - R&D | Waltham, MA | Jul 30, 2026 | Oct 11, 2026 | Senior |
| Vice President, Pharmacovigilance | Waltham, MA | Jul 9, 2026 | Oct 11, 2026 | Executive |
| Vice President, Program Team Leader | Waltham, MA | Jun 22, 2026 | Oct 11, 2026 | Executive |
| Executive Director, Regulatory Affairs CMC | Waltham, MA | May 29, 2026 | Oct 11, 2026 | Executive |
| Executive Director/Vice President, Medical Lead | Waltham, MA | Oct 30, 2025 | Oct 11, 2026 | Executive |
Connect
See your connections at Crescent Biopharma on LinkedIn (search by name, results not checked)